Cargando…
Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
Malignant pericardial effusion (MPCE) is a common complication of advanced malignant tumors, and interferes severely with patient prognosis and quality of life. The standard treatment for this complication is intracavitary perfusion of chemotherapeutic drugs, which is limited by unsatisfactory thera...
Autores principales: | Chen, Dawei, Zhang, Yan, Shi, Fang, Li, Minghuan, Zhu, Hui, Kong, Li, Yu, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599051/ https://www.ncbi.nlm.nih.gov/pubmed/26491350 http://dx.doi.org/10.2147/OTT.S90145 |
Ejemplares similares
-
Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients
por: Chen, Dawei, et al.
Publicado: (2016) -
Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion
por: Prado de Morais, Fabíola, et al.
Publicado: (2020) -
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
por: Kunitoh, H, et al.
Publicado: (2009) -
Unusual intrapericardial pressure pattern in localized pericardial effusion
por: Yalonetsky, Sergey, et al.
Publicado: (2020) -
Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
por: Moriya, T, et al.
Publicado: (2000)